Trial reportBMC complementary medicine and therapies2025
The effects of Pranayama breathing exercise on symptom burden among women with breast cancer undergoing chemotherapy: a randomized controlled trial.
Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPranayama breathing exercises may help reduce the burden of chemotherapy-induced symptoms in women with breast cancer. The aim of this study was to determine the effect of pranayama breathing exercise on symptom burden in women with breast cancer undergoing chemotherapy.
methodsIn this clinical trial, 76 participants were randomly assigned to two groups: pranayama breathing exercise plus routine care (intervention group) (n = 38) or routine care (control group) (n = 38). Patients were asked to perform pranayama breathing twice a day for 10 min for 21 days (one week before chemotherapy to 14 days after the start of chemotherapy). Symptom burden was measured through the MD Anderson Symptom Inventory (MDASI) before the intervention, on the first day of chemotherapy, on day 7 and on day 14 after chemotherapy.
resultsA significant decrease in the total score of symptom burden and subscales of symptom severity and symptom interference with daily activities was shown in the intervention group compared with the control group at all three measurement points (η
conclusionsPranayama breathing exercise was effective in reducing the symptom burden in women with breast cancer undergoing chemotherapy. It is recommended that the pranayama breathing be considered as a component of comprehensive cancer care. Nurses should teach patients pranayama breathing as an independent nursing intervention to reduce the burden of chemotherapy-induced symptoms.
trial registrationThis trial has been registered on the Iranian Registry of Clinical Trials ( http://www.irct.ir ) with the identifier (IRCT20231212060343N1). Registered date: 23/01/2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.